Contract 36F79721D0227
Amivas Us Llc · Department Of Veterans Affairs · October 28, 2025
Amivas Us Llc was awarded a federal contract by Department Of Veterans Affairs on October 28, 2025 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 23, 2026. If all options are exercised, the contract could reach $225,000.
Contract details
- PIID
- 36F79721D0227
- Award type
- Fss
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- October 28, 2025
- Latest action
- March 23, 2026
Description
TEMP K EXTENSION
Modification timeline
-
March 23, 2026Mod P00009 · Supplemental Agreement For Work Within Scope$0
-
March 23, 2026Mod P00009$0
-
December 15, 2025Mod P00008 · Supplemental Agreement For Work Within ScopeFSS$0
-
October 28, 2025Mod P00007 · Supplemental Agreement For Work Within ScopeADMIN MOD REVISION TO 2025 PUBLIC LAW PRICING UPDATE$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Regimed Medical | Department Of Veterans Affairs | July 2, 2026 | $292.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79721D0227?
Contract 36F79721D0227 is a federal contract awarded to Amivas Us Llc by Department Of Veterans Affairs on October 28, 2025 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 3 times since the base award.
Who won contract 36F79721D0227?
Amivas Us Llc won contract 36F79721D0227 from Department Of Veterans Affairs.
How much is contract 36F79721D0227 worth?
Contract 36F79721D0227 has obligated $0 to date but carries a potential ceiling of $225,000 if fully funded and all options are exercised.